Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01057290
What this trial is testing

Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 75
Testing effectiveness (Phase 2)Looking for participantsNCT07256782
What this trial is testing

QLC5508 Combinations in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Qilu Pharmaceutical Co., Ltd. 444
Not applicableStudy completedNCT00156312
What this trial is testing

Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine

Who this might be right for
Breast Cancer
University of Michigan Rogel Cancer Center 25
Not applicableUnknownNCT05953909
What this trial is testing

Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01).

Who this might be right for
Breast Cancer
Fujian Cancer Hospital 120
Early research (Phase 1)Looking for participantsNCT06515613
What this trial is testing

CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Who this might be right for
Platinum-resistant Ovarian CancerTesticular CancerEndometrial Cancer
Context Therapeutics Inc. 156
Testing effectiveness (Phase 2)Looking for participantsNCT06789848
What this trial is testing

Ligufalimab and Cadonilimab in Advanced Liver Cancers

Who this might be right for
Advanced Hepatocellular CarcinomaRefractory Hepatocellular CarcinomaBiliary Tract Cancer
University of Texas Southwestern Medical Center 64
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT00006255
What this trial is testing

Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases

Who this might be right for
Kidney CancerMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 17
Not applicableStudy completedNCT01138358
What this trial is testing

Study of Episodic Breathlessness in Patients With Lung Cancer or Other Advanced Disease

Who this might be right for
DyspneaLung CancerMetastatic Cancer
King's College Hospital NHS Trust 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07841925
What this trial is testing

BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 30
Not applicableActive Not RecruitingNCT02371135
What this trial is testing

Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes

Who this might be right for
Lynch SyndromeHereditary Colonic Polyposis Syndromes
Memorial Sloan Kettering Cancer Center 77
Testing effectiveness (Phase 2)Ended earlyNCT02842125
What this trial is testing

Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Solid Tumor CancerRecurrent Head and Neck Cancer
MultiVir, Inc. 4
Not applicableStudy completedNCT01142661
What this trial is testing

Compassionate Use of Eribulin for the Treatment of Advanced Breast Cancer Refractory to All Other Marketed Therapies

Who this might be right for
Breast Cancer
Eisai Inc. 9
Not applicableNot Yet RecruitingNCT07732686
What this trial is testing

Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry

Who this might be right for
Pancreas CancerHepatocellular CarcinomaLung Cancer+6 more
University of Oklahoma 2,000
Not applicableStudy completedNCT03736746
What this trial is testing

Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals

Who this might be right for
Other Cancer
Dana-Farber Cancer Institute 54
Not applicableEnrolling By InvitationNCT06894927
What this trial is testing

Hearing Screening in Adults Over 50 Years Old

Who this might be right for
Hearing Loss, Bilateral Sensorineural, ProgressiveHearing Loss, Bilateral (Causes Other Than Tumors)Hearing Loss, Bilateral or Unilateral+1 more
University Hospital Hradec Kralove 330
Not applicableStudy completedNCT03535623
What this trial is testing

RIPC During Free Flap With Preoperative Radiotherapy

Who this might be right for
Ischemic Reperfusion InjuryOther Reconstructive SurgeryRadiotherapy
Seoul National University Hospital 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07811232
What this trial is testing

AL58805 in Advanced, Metastatic GYN, STS or Breast Cancers

Who this might be right for
Endometrial NeoplasmsSoft Tissue Sarcoma (STS)Breast Neoplasms
Advenchen Pharmaceuticals, LLC. 138
Large-scale testing (Phase 3)Looking for participantsNCT04702581
What this trial is testing

Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery

Who this might be right for
OligodendrogliomaLow-grade Oligodendroglioma1p19q Codeletion
Hospices Civils de Lyon 280
Testing effectiveness (Phase 2)Ended earlyNCT03288545
What this trial is testing

Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

Who this might be right for
Carcinoma, Transitional CellUrinary Bladder NeoplasmsUrologic Neoplasms+4 more
Astellas Pharma Global Development, Inc. 348
Next Page